Biological effectiveness of antiproton annihilation

Carl Maggiore, Nzhde Agazaryan, Niels Bassler, Ewart Blackmore, Gerd Beyer, John J. DeMarco, Michael Doser, Charles R. Gruhn, Michael H. Holzscheiter, Toshiyasu Ichioka, Keisuke S. Iwamoto, Helge V. Knudsen, Rolf Landua, William H. McBride, Søren Pape Møller, Jorgen Petersen, James B. Smathers, Lloyd D. Skarsgard, Timothy D. Solberg, Ulrik I. UggerhøjH. Rodney Withers, Bradly G. Wouters

Research output: Contribution to journalConference articlepeer-review

18 Scopus citations


A new experiment, AD-4/ACE (antiproton cell experiment), has been approved by the CERN Research Board. The experiment is scheduled to begin taking data in June and continue through the 2003 run cycle. The experiment is designed to determine whether or not the densely ionizing particles emanating from the annihilation of antiprotons produce an increase in "biological dose" in the vicinity of the narrow Bragg peak for antiprotons compared to protons. This experiment is the first direct measurement of the biological effects of antiproton annihilation. The background, description, and status of the experiment are given.

Original languageEnglish (US)
Pages (from-to)181-185
Number of pages5
JournalNuclear Instruments and Methods in Physics Research, Section B: Beam Interactions with Materials and Atoms
Issue numberSUPPL.
StatePublished - Jan 2004
EventLow Energy Antiproton Physics (LEAP'03) - Jamashita-park, Japan
Duration: Mar 3 2003Mar 7 2003


  • Antiproton annihilation
  • Biological response
  • Bragg peak

ASJC Scopus subject areas

  • Nuclear and High Energy Physics
  • Instrumentation


Dive into the research topics of 'Biological effectiveness of antiproton annihilation'. Together they form a unique fingerprint.

Cite this